Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05149222 · ClinicalTrials.gov registry record · NA
"REACT-FM-EXT": Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia: An Extension Study
A NA study, sponsored by Swing Therapeutics.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT05149222 is a NA study that has completed, run by Swing Therapeutics. The registered enrollment target is 50 participants.
The verdict
NCT05149222, a NA study, has completed, sponsored by Swing Therapeutics.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This is an extension study of REACT-FM. The primary objective of the study is to assess the response to digital therapy in the treatment of fibromyalgia over an additional 9 months.
Interventions
- DEVICE Digital ACT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-11-30 |
| Est. Completion | 2024-04-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05149222
The ClinicalTrials.gov registry entry for NCT05149222 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Swing Therapeutics, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Digital ACT is the first listed.
NCT05149222 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05149222 about?
NCT05149222 is a clinical study titled ""REACT-FM-EXT": Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia: An Extension Study". This is an extension study of REACT-FM. The primary objective of the study is to assess the response to digital therapy in the treatment of fibromyalgia over an additional 9 months.
What is the current status of trial NCT05149222?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2021-11-30. Estimated completion is 2024-04-14.
What interventions are being tested in trial NCT05149222?
The interventions under investigation include: Digital ACT (DEVICE).
Who is sponsoring clinical trial NCT05149222?
This trial is sponsored by Swing Therapeutics, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.